59 related articles for article (PubMed ID: 2228827)
1. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
2. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.
Aldridge KE; Ashcraft D; Cambre K; Pierson CL; Jenkins SG; Rosenblatt JE
Antimicrob Agents Chemother; 2001 Apr; 45(4):1238-43. PubMed ID: 11257040
[TBL] [Abstract][Full Text] [Related]
3. Novel and rare β-lactamase genes of Bacteroides fragilis group species: Detection of the genes and characterization of their genetic backgrounds.
Mahmood B; Sárvári KP; Orosz L; Nagy E; Sóki J
Anaerobe; 2024 Apr; 86():102832. PubMed ID: 38360202
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility testing of anaerobic bacteria: evaluation of the redesigned (Version 96) bioMérieux ATB ANA device.
Dubreuil L; Houcke I; Singer E
J Clin Microbiol; 1999 Jun; 37(6):1824-8. PubMed ID: 10325331
[TBL] [Abstract][Full Text] [Related]
5. Genomic analyses of
English J; Newberry F; Hoyles L; Patrick S; Stewart L
J Med Microbiol; 2023 Nov; 72(11):. PubMed ID: 37910167
[No Abstract] [Full Text] [Related]
6. Comparative metabolomics reveal key pathways associated with the synergistic activities of aztreonam and clavulanate combination against multidrug-resistant
Zhang J; Yang H; Zhang L; Lv Z; Yu M; Sy SKB; Zhan Y
mSystems; 2023 Dec; 8(6):e0075823. PubMed ID: 37830827
[TBL] [Abstract][Full Text] [Related]
7. Proteomics-Based RT-qPCR and Functional Analysis of 18 Genes in Metronidazole Resistance of
Mahmood B; Paunkov A; Kupc M; Burián K; Nagy E; Leitsch D; Sóki J
Antibiotics (Basel); 2024 Feb; 13(3):. PubMed ID: 38534642
[TBL] [Abstract][Full Text] [Related]
8. Gut Bacteroides act in a microbial consortium to cause susceptibility to severe malaria.
Mandal RK; Mandal A; Denny JE; Namazii R; John CC; Schmidt NW
Nat Commun; 2023 Oct; 14(1):6465. PubMed ID: 37833304
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility and tolerance of beta-lactamase-producing, methicillin-sensitive strains of Staphylococcus aureus towards seven broad-spectrum penicillins.
Wehrli R; von Graevenitz A; Lüthy R
Infection; 1983; 11(6):322-5. PubMed ID: 6607889
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of action of beta-lactam antibiotics and mechanisms of non-enzymatic resistance].
Williamson R; Collatz E; Gutmann L
Presse Med; 1986 Dec; 15(46):2282-9. PubMed ID: 2949269
[TBL] [Abstract][Full Text] [Related]
11. Dps and DpsL Mediate Survival In Vitro and In Vivo during the Prolonged Oxidative Stress Response in Bacteroides fragilis.
Betteken MI; Rocha ER; Smith CJ
J Bacteriol; 2015 Oct; 197(20):3329-38. PubMed ID: 26260459
[TBL] [Abstract][Full Text] [Related]
12. Comparative antianaerobic activities of doripenem determined by MIC and time-kill analysis.
Credito KL; Ednie LM; Appelbaum PC
Antimicrob Agents Chemother; 2008 Jan; 52(1):365-73. PubMed ID: 17938185
[TBL] [Abstract][Full Text] [Related]
13. Time-kill studies of the antianaerobe activity of garenoxacin compared with those of nine other agents.
Credito KL; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2003 Apr; 47(4):1399-402. PubMed ID: 12654677
[TBL] [Abstract][Full Text] [Related]
14. In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds.
Hoellman DB; Kelly LM; Credito K; Anthony L; Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2002 Jan; 46(1):220-4. PubMed ID: 11751138
[TBL] [Abstract][Full Text] [Related]
15. Quinolone activity against anaerobes.
Appelbaum PC
Drugs; 1999; 58 Suppl 2():60-4. PubMed ID: 10553708
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds.
Hoellman DB; Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Mar; 42(3):495-501. PubMed ID: 9517922
[TBL] [Abstract][Full Text] [Related]
17. Quinolone activity against anaerobes: microbiological aspects.
Appelbaum PC
Drugs; 1995; 49 Suppl 2():76-80. PubMed ID: 8549420
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
